SEARCH

SEARCH BY CITATION

References

  • 1
    Yarchoan R, Pluda JM, Perno CF, et al: Anti-retroviral therapy of human immunodeficiency virus infection: Current strategies and challenges for the future. Blood 78: 859884, 1991.
  • 2
    Gail MH, Pluda JM, Rabkin CS, et al: Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst 83: 695701, 1991.
  • 3
    Pluda JM, Yarchoan R, Jaffe ES, et al: Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med 113: 276282, 1990.
  • 4
    Groopman JE, Broder S: Cancers in AIDS and other immunodeficiency states, in DeVitaVT, HellmanS, RosenbergSA (eds): Cancer: Principles and Practice of Oncology, ed 3. Philadelphia, JB Lippincott, 1989, pp 19531970.
  • 5
    Safai B, Schwartz JJ, Dias BM: Malignant neoplasms associated with human immunodeficiency virus infection. Ca Cancer J Clin 42: 7495, 1992.
  • 6
    Yarchoan R, Venzon DJ, Pluda JM, et al: CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med 115: 184189, 1991.
  • 7
    Feichtinger H, Putkonen P, Parravicini C, et al: Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus. Am J Pathol 137: 13111315, 1990.
  • 8
    Cremer KJ, Spring SB, Gruber J: Role of human immunodeficiency virus type 1 and other viruses in malignancies associated with acquired immunodeficiency disease syndrome. J Natl Cancer Inst 82: 10161024, 1990.
  • 9
    Neri A, Barriga F, Inghirami G, et al: Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 77: 10921095, 1991.
  • 10
    Shibata D, Weiss LM, Nathwani BN, et al: Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 77: 15271533, 1991.
  • 11
    Gauwerky CE, Croce CM: Molecular biology of leukemias and lymphomas, in BroderS (ed): Molecular Foundations of Oncology, Baltimore, Williams & Wilkins, 1991, pp 295310.
  • 12
    Ladanyi M, Offit K, Jhanwar SC, et al: MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood 77: 10571063, 1991.
  • 13
    Ensoli B, Nakamura S, Salahuddin SZ, et al: AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243: 223226, 1989.
  • 14
    Ensoli B, Barillari G, Salahuddin SZ, et al: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345: 8486, 1990.
  • 15
    Miles SA, Rezai AR, Salazar-Gonzalez JF, et al: AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 87: 40684072, 1990.
  • 16
    Folkman J, Weisz PB, Joullie MM, et al: Control of angiogenesis with synthetic heparin substitutes. Science 243: 14901493, 1989.
  • 17
    Ingber D, Fujita T, Kishimoto S, et al: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555557, 1990.
  • 18
    Birx DL, Redfield RR, Tencer K, et al: Induction of interleukin-6 during human immunodeficiency virus infection. Blood 76: 23032310, 1990.
  • 19
    Moore KW, Vieira P, Fiorentino DF, et al: Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248: 12301234, 1990.
  • 20
    Kiviat N, Rompalo A, Bowden R, et al: Anal human papilloma-virus infection among human immunodeficiency virus-seropositive and -seronegative men. J Infect Dis 162: 358361, 1990.
  • 21
    Maiman M, Fruchter RG, Serur E, et al: Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 38: 377382, 1990.
  • 22
    Chadwick EG, Connor EJ, Hanson CG, et al: Tumors of smooth muscle origin in HIV-infected children. JAMA 263: 31823184, 1990.
  • 23
    Sidell N, Taga T, Hirano T, et al: Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J Immunol 146: 38093814, 1991.
  • 24
    Fazely F, Dezube BJ, Allen-Ryan J, et al: Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type I in human peripheral blood mononuclear cells and in cultured T cells. Blood 77: 16531656, 1991.
  • 25
    Pluda JM, Yarchoan R, Smith PD, et al: Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. Blood 76: 463472, 1990.
  • 26
    Szczylik C, Skorski T, Nicolaides NC, et al: Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxy-nucleotides. Science 253: 562565, 1991.
  • 27
    McManaway ME, Neckers LM, Loke SL, et al: Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet 335: 808811, 1990.
  • 28
    Reed JC, Stein C, Subasinghe C, et al: Antisense-mediated inhibition of fBCL-2 protooncogene expression and leukemic cell growth and survival: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res 50: 65656570, 1990.
  • 29
    Sullenger BA, Gallardo HF, Ungers GE, Gilboa E: Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63: 601608, 1990.
  • 30
    Delli-Bovi P, Curatola AM, Kern FG, et al: An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 50: 729737, 1987.